page contents

Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference

After brutal losses to end 2018, the biotech sector is off to the best start of the year since 2012.

Two new deals to start the year and positive trial presentations at the J.P. Morgan Health Care Conference have breathed new life into some of last year’s biggest stock losers.


Health and Science

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close